PNA targeting the PBS and A-loop sequences of HIV-1 genome destabilizes packaged tRNA3Lys in the virions and inhibits HIV-1 replication

Virology

Volumn 303, Issue 2, 2002, Pages 297-308

  Kaushik, Neerja ^a   Pandey, Virendra N ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; PEPTIDE NUCLEIC ACID; TRANSFER RNA; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; VIRION; VIRUS GENOME; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0036934961     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2002.1630     Document Type: Article

References (45)

1. Aldrian-Herrada, G., Desarmenien, M. G., Orcel, H., Boissin-Agasse, L., Mery, J., Brugidou, J., and Rabie, A. (1998). A peptide nucleic acid (PNA) is more rapidly internalized in cultured neurons when coupled to a retro-inverso delivery peptide. The antisense activity depresses the target mRNA and protein in magnocellular oxytocin neurons. Nucleic Acids Res. 26, 4910-4916.
2. lys-3 as primers in an endogenous human immunodeficiency virus-1 in vitro reverse transcription/template-switching reaction. J. Biol. Chem. 269, 14672-14680.
3. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. S., Smith, J. A., and Struhl, K. (1998). "Current Protocols in Molecular Biology." Greene Publishing Associates and Wiley-Intersciences, Wiley, New York.
4. Branden, L. J., Mohamed, A. J., and Smith, C. I. (1999). A peptide nucleic acid-nuclear localization signal fusion that mediates nuclear transport of DNA. Nat. Biotechnol. 17, 784-787.
5. Chinnery, P. F., Taylor, R. W., Diekert, K., Lill, R., Turnbull, D. M., and Lightowlers, R. N. (2000). Peptide nucleic acid delivery to human mitochondria. Gene Ther. 6, 1919-1928.
6. Cullen, B. R., and Greene, W. C. (1990). Functions of the auxiliary gene products of the human immunodeficiency virus type 1. Virology 178, 1-5.
7. Lys. J. Virol. 69, 3090-3097.
8. Demidov, V. V., Potaman, V. N., Frank-Kamenetskii, M. D., Egholm, M., Buchardt, O., Sonnichsen, S. H., and Nielsen, P. E. (1994). Stability of peptide nucleic acids in human serum and cellular extracts. Biochem. Pharmacol. 48, 1310-1313.
9. Dias, N., Dheur, S., Nielsen, P. E., Gryaznov, S., Van Aerschot, A., Herdewijn, P., Helene, C., and Saison-Behmoaras, T. E. (1999). Anti-sense PNA targeted to the coding region of Ha-ras mRNA arrest polypeptide chain elongation. J. Mol. Biol. 294, 403-416.
10. Egholm, M., Buchardt, O., Christensen, L., Beherens, C., Freier, S. M., Driver, D. A., Berg, R. H., Kim, S. K., Norden, B., and Nielsen, P. E. (1993). PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick Hydrogen bonding rules. Nature 365, 566-568.
11. Embretson, J., Zupancic, M., Ribas, J. L., Burke, E., Racz, P., Tenner-Racz, K., and Haase, A. T. (1993). Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362, 359-362.
12. Fraser, G. L., Holmgren, J., Clarke, P. B., and Wahlestedt, C. (2000). Antisense inhibition of delta-opioid receptors gene function in vivo by peptide nucleic acids. Mol. Pharmacol. 57, 725-731.
13. Hamilton, S. E., Simmons, C. G., Kathiriya, I. S., and Corey, D. R. (1999). Cellular delivery of peptide nucleic acids and inhibition of human telomerase. Chem. Biol. 6, 343-351.
14. Harrich, D., Ulich, C., Garcia-Martinez, L. F., and Gaynor, R. B. (1997). Tat is required for efficient HIV-1 reverse transcription. EMBO J. 16, 1224-1235.
15. Harrison, J. G., Frier, C., Laurant, R., Dennis, R., Raney, K. D., and Balasubramanian, S. (1999). Inhibition of human telomerase by PNA-cationic peptide conjugates. Bioorg. Med. Chem. Lett. 9, 1273-1278.
16. Helene, C. (1997). Specific control of gene expression by oligonucleotides: From chemistry to clinical aspects. Ann. Pharm. Fr. 55, 95-103.
17. Herbert, B., Pitts, A. E., Baker, S. I., Hamilton, S. E., Wright, W. E., Shay, J. W., and Corey, D. R. (1999). Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proc. Natl. Acad. Sci. USA 96, 14276-14281.
18. Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M., and Markowitz, M. (1995). Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123-126.
19. Lys anticodon on the initiation of human immunodeficiency virus type 1 reverse transcription. J. Virol. 70, 4700-4706.
20. Jiang, M., Mak, J., Ladha, A., Cohen, E., Klein, M., Rovinski, B., and Kleiman, L. (1993). Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1. J. Virol. 67, 3246-3253.
21. Kamagai, I., Takahashi, T., Hamasaki, K., Ueno, A., and Mihara, H. (2000). Construction of HIV Rev peptides containing peptide nucleic acid that bind HIV RRE IIB RNA. Bioorg. Med. Chem. Lett. 10, 377-379.
22. Lys from the primer binding site of HIV-1 genome by anti-A loop polyamide nucleic acid. Nucleic Acid Res. 29, 5099-5106.
23. Kaushik, N., Basu, A., Palumbo, P., Meyers, R., and Pandey, V. N. (2002). Anti-TAR polyamide nucleic acid transportan conjugate inhibits Tat-mediated transactivation of HIV-1 LTR. J. Virol. 76, 3881-3891.
24. Larder, B. A. (1993). In "Reverse Transcriptase" (A. M. Skalka and S. P. Goff, Eds.), p. 205. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
25. Lee, R., Kaushik, N., Modak, M. J., Vinayak, R., and Pandey, V. N. (1997). Polyamide nucleic acid targeted to the primer binding site of the HIV-1 RNA genome blocks in vitro HIV-1 reverse transcription. Biochemistry 37, 900-910.
26. Leeds, J. M., Henry, S. P., Truong, L., Zutshi, A., Levin, A. A., and Kornbrust, D. (1997). Pharmacokinetics of a potential human cyto-megalovirus therapeutic, a phosphorothioate oligonucleotide, after intravitreal injection in the rabbit. Drug Metab. Dispos. 25, 921-926.
27. Li, Y., Kang, S. M., and Morrow, C. D. (1997). Stability of HIV type 1 proviral genomes that contain two distinct primer-binding sites. AIDS Res. Hum. Retroviruses 13, 253-262.
28. Ljungstrom, T., Knudsen, H., and Nielsen, P. E. (1999). Cellular uptake of adamantyl conjugated peptide nucleic acids. Bioconjug. Chem. 10, 965-972.
29. Mayhood, T., Kaushik, N., Pandey, P. K., Kashanchi, F., Deng, L., and Pandey, V. N. (2000). Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element. Biochemistry 39, 11532-11539.
30. Mollegaard, N. E., Buchardt, O., Egholm, M., and Nielsen, P. E. (1994). Peptide nucleic acid. DNA strand displacement loops as artificial transcription promoters. Proc. Natl. Acad. Sci. USA 91, 3892-3895.
31. Mologni, L., Nielsen, P. E., and Gambacorti-Passerini, G. (1999). In vitro transcriptional and translational block of the bcl-2 gene operated by peptide nucleic acid. Biochem. Biophys. Res. Commun. 264, 537-543.
32. Muesing, M. A., Smith, D. H., and Capon, D. J. (1987). Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein. Cell 48, 691-701.
33. Nielsen, P. E., Egholm, M., Berg, R. H., and Buchardt, O. (1991). Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science 254, 1497-1500.
34. Peffer, N. J., Hanvey, J. C., Bisi, J. E., Thomson, S. A., Hassman, C. F., Noble, S. A., and Babiss, L. E. (1993). Strand-invasion of duplex DNA by peptide nucleic acid oligomers. Proc. Natl. Acad. Sci. USA 90, 10648-10652.
35. Planelles, V., Bachelerie, F., Jowett, J. B., Haislip, A., Xie, Y., Banooni, P., Masuda, T., and Chen, I. S. (1995). Fate of the human immunodeficiency virus type 1 provirus in infected cells: A role for vpr. J. Virol. 69(9), 5883-5889.
36. Pooga, M., Soomets, U., Hallbrink, M., Valkna, A., Saar, K., Rezaei, K., Kahl, U., Hao, J. X., Xu, X. J., Wiesenfeld-Hallin, Z., Hokfelt, T., Bartfai, T., and Langel, U. (1998). Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat. Biotech. 16, 857-861.
37. Ratner, L. W., Haseltine, W. A., Patarca, R., Livak, K. J., Starcich, B., Josephs, S. F., Doran, E. R., Rafalski, J. A., Whitehorn, E. A., Baumeister, K., Ivanoff, L., Petteway, S. R., Jr., Pearson, M. L., Lautenberger, J. A., Papas, S. R., Ghrayeb, J., Chang, N. T., Gallo, R. C., and Wong-Stall, F. (1985). Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 313, 277-284.
38. Sanger, F., Nicklen, S., and Coulson, A. R. (1977). DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74, 5463-5467.
39. Scarfi, S., Giovine, M., Gasparini, A., Damonte, G., Millo, E., Pozzolini, M., and Benatti, U. (1999). Modified peptide nucleic acids are internalized in mouse macrophages RAW 264.7 and inhibit inducible nitric oxide synthase. FEBS Lett. 451, 264-268.
40. Shammas, M. A., Simmons, C. G., Corey, D. R., and Reis, R. J. (1999). Telomerase inhibition by peptide nucleic acids reverses "immortality" of transformed human cells. Oncogene 18, 6191-6200.
41. Sherman, P. A., Dickson, M. L., and Fyfe, J. A. (1992). Human immunodeficiency virus type 1 integration protein: DNA sequence requirements for cleaving and joining reactions. J. Virol. 66, 3593-3601.
42. Stein, C. A. (1999). Keeping the biotechnology of antisense in context. Nat. Biotech. 17, 209.
43. Vink, C., Van Gent, D. C., Elgersma, Y., and Plasterk, R. H. A. (1991). Human immunodeficiency virus integrase protein requires a subterminal position of its viral DNA recognition sequence for efficient cleavage. J. Virol. 65, 4636-4644.
44. Wakefield, J. K., Kang, S., and Morrow, C. D. (1996). Construction of a type 1 human immunodeficiency virus that maintains a primer binding site complementary to tRNA (His). J. Virol. 70, 966-975.
45. Wei, X., Ghos, S. K., Taylor, M. E., Johnson, V. A., Emini, E. A., Deutsch, P., Lifson, J. D., Bonhoeffer, S., Nowak, M. A., Hahn, B. H., Sag, M. S., and Shaw, G. M. (1995). Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373, 117-122.